SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway

Mesenchymal stem cells (MSCs) are thought to have great potential in the therapy of acute liver injury. It is possible that these cells may be regulated by the stromal cell-derived factor-1 (SDF-1)/CXC chemokine receptor-4 (CXCR4) signaling axis, which has been shown to promote stem cells migration...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiu, Guanghui, Li, Xiuling, Yin, Yunyu, Li, Jintao, Li, Bingqin, Chen, Xianzhong, Liu, Ping, Sun, Jie, Ling, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563832/
https://www.ncbi.nlm.nih.gov/pubmed/32452221
http://dx.doi.org/10.1177/0963689720929992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563832/
https://www.ncbi.nlm.nih.gov/pubmed/32452221
http://dx.doi.org/10.1177/0963689720929992

Ejemplares similares